Edinburgh Molecular Imaging Ltd:製品パイプライン分析

◆英語タイトル:Edinburgh Molecular Imaging Ltd - Product Pipeline Analysis, 2017 Update
◆商品コード:DATA8010108
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月27日
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD750 ⇒換算¥109,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD1,500 ⇒換算¥219,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥328,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Edinburgh Molecular Imaging Ltd (EM Imaging) is a clinical phase biotechnology company that develops optical molecular imaging technology. It is involved in the discovery and development of small molecules and peptides. The company designs agents to improve the diagnosis and treatment of cancer and lung diseases. Its portfolio of agents includes EMI-137 (CRC Lesion); EMI-200 (Inflammation); EMI-300/350 (Lung Infection); EMI-400 (Lung Fibrosis); EMI-500 (Breast Cancer); and EMI-600 (Single Pulmonary Nodules). SMART Agent optical imaging platform is the foundation technology, which shows the increased fluorescent signal from the optical agents on target engagement in a diseased patient. EM Imaging is headquartered in Edinburgh, Scotland, the UK.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Edinburgh Molecular Imaging Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Edinburgh Molecular Imaging Ltd Company Overview 4
Edinburgh Molecular Imaging Ltd Company Snapshot 4
Edinburgh Molecular Imaging Ltd Pipeline Products and Ongoing Clinical Trials Overview 4
Edinburgh Molecular Imaging Ltd – Pipeline Analysis Overview 7
Edinburgh Molecular Imaging Ltd – Key Facts 7
Edinburgh Molecular Imaging Ltd – Major Products and Services 8
Edinburgh Molecular Imaging Ltd Pipeline Products by Development Stage 9
Edinburgh Molecular Imaging Ltd Ongoing Clinical Trials by Trial Status 11
Edinburgh Molecular Imaging Ltd Pipeline Products Overview 13
EMI-137 13
EMI-137 Product Overview 13
EMI-137 Clinical Trial 14
EMI-200 15
EMI-200 Product Overview 15
EMI-300/350 16
EMI-300/350 Product Overview 16
EMI-400 17
EMI-400 Product Overview 17
EMI-500 18
EMI-500 Product Overview 18
EMI-600 19
EMI-600 Product Overview 19
Edinburgh Molecular Imaging Ltd – Key Competitors 20
Edinburgh Molecular Imaging Ltd – Key Employees 21
Edinburgh Molecular Imaging Ltd – Locations And Subsidiaries 22
Head Office 22
Recent Developments 23
Edinburgh Molecular Imaging Ltd, Recent Developments 23
Sep 20, 2017: Edinburgh Molecular Imaging Commences Phase II European Cancer Trial 23
Mar 09, 2016: Edinburgh Molecular Imaging Awarded Innovate UK Grant To Qualify The Role Of EMI-137 In Colorectal Cancer Lesion Detection 23
Appendix 25
Methodology 25
About GlobalData 27
Contact Us 27
Disclaimer 28

List of Tables
Edinburgh Molecular Imaging Ltd Pipeline Products and Ongoing Clinical Trials Overview 4
Edinburgh Molecular Imaging Ltd Pipeline Products by Equipment Type 5
Edinburgh Molecular Imaging Ltd Pipeline Products by Indication 6
Edinburgh Molecular Imaging Ltd Ongoing Clinical Trials by Trial Status 6
Edinburgh Molecular Imaging Ltd, Key Facts 7
Edinburgh Molecular Imaging Ltd, Major Products and Services 8
Edinburgh Molecular Imaging Ltd Number of Pipeline Products by Development Stage 9
Edinburgh Molecular Imaging Ltd Pipeline Products Summary by Development Stage 10
Edinburgh Molecular Imaging Ltd Ongoing Clinical Trials by Trial Status 11
Edinburgh Molecular Imaging Ltd Ongoing Clinical Trials Summary 12
EMI-137 - Product Status 13
EMI-137 - Product Description 13
EMI-137 - A Phase IIb, Open Label Study for the Detection of Dysplastic Colorectal Polyps during Colonoscopy after EMI-137 Injection in Patients with High Risk of Colorectal Cancer 14
EMI-200 - Product Status 15
EMI-200 - Product Description 15
EMI-300/350 - Product Status 16
EMI-300/350 - Product Description 16
EMI-400 - Product Status 17
EMI-400 - Product Description 17
EMI-500 - Product Status 18
EMI-500 - Product Description 18
EMI-600 - Product Status 19
EMI-600 - Product Description 19
Edinburgh Molecular Imaging Ltd, Key Employees 21
Glossary 26

★海外企業調査レポート[Edinburgh Molecular Imaging Ltd:製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Kaiser Foundation Health Plan Inc:企業の戦略的SWOT分析
    Kaiser Foundation Health Plan Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • MAB Discovery GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary MAB Discovery GmbH (MAB Discovery) is a drug discovery and development company that offers novel antibody therapeutics. The company produces monoclonal antibodies derived from rabbits and rats by employing biochemical and cellular based screens. It relies on natural immune response and B cel …
  • SSBV-Rovsing A/S:企業の戦略・SWOT・財務情報
    SSBV-Rovsing A/S - Strategy, SWOT and Corporate Finance Report Summary SSBV-Rovsing A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Lindsay Corporation:企業の戦略・SWOT・財務情報
    Lindsay Corporation - Strategy, SWOT and Corporate Finance Report Summary Lindsay Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • ResApp Health Ltd (RAP):医療機器:M&Aディール及び事業提携情報
    Summary ResApp Health Ltd (ResApp) formerly, Narhex Life Sciences Limited is a digital health company that develops smartphone applications for the diagnosis and management of respiratory disease. It's digital healthcare solutions assist doctors and patients to diagnose and manage respiratory diseas …
  • Macy’s Inc:企業の戦略・SWOT・財務情報
    Macy's Inc - Strategy, SWOT and Corporate Finance Report Summary Macy's Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Reliance Capital Ltd:企業のM&A・事業提携・投資動向
    Reliance Capital Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Reliance Capital Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Columbia Power Corp:企業の戦略的SWOT分析
    Columbia Power Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Maines Paper & Foodservice, Inc.:企業の戦略・SWOT・財務情報
    Maines Paper & Foodservice, Inc. - Strategy, SWOT and Corporate Finance Report Summary Maines Paper & Foodservice, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • CONSOL Energy Inc.:企業の戦略・SWOT・財務分析
    CONSOL Energy Inc. - Strategy, SWOT and Corporate Finance Report Summary CONSOL Energy Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Ortho-Clinical Diagnostics Inc:企業のM&A・事業提携・投資動向
    Ortho-Clinical Diagnostics Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ortho-Clinical Diagnostics Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Rajesh Exports Limited
    Rajesh Exports Limited - Strategy, SWOT and Corporate Finance Report Summary Rajesh Exports Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • SgurrEnergy Ltd:企業の戦略的SWOT分析
    SgurrEnergy Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Ingram Entertainment Inc.:戦略・SWOT・企業財務分析
    Ingram Entertainment Inc. - Strategy, SWOT and Corporate Finance Report Summary Ingram Entertainment Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Hindalco Industries Ltd:戦略・SWOT・企業財務分析
    Hindalco Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Hindalco Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Nilkamal Ltd:企業の戦略・SWOT・財務情報
    Nilkamal Ltd - Strategy, SWOT and Corporate Finance Report Summary Nilkamal Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • ThyssenKrupp AG:企業のM&A・事業提携・投資動向
    ThyssenKrupp AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ThyssenKrupp AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Taisho Pharmaceutical Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Taisho Pharmaceutical Co Ltd (Taisho), a subsidiary of Taisho Pharmaceutical Holdings Co Ltd is a pharmaceutical company that develops, manufactures and markets a range of prescription pharmaceutical and self-medication drugs. The company offers products such as lipovitan D, riup, clarith, z …
  • Bel Fuse, Inc.:企業の戦略・SWOT・財務分析
    Bel Fuse, Inc. - Strategy, SWOT and Corporate Finance Report Summary Bel Fuse, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • National Presto Industries Inc (NPK):企業の財務・戦略的SWOT分析
    Summary National Presto Industries Inc (National Presto) operates as a consumer product manufacturer that provides pressure cookers and electric appliances. The company provides products such as clocks and timers, coffee makers, bacon cookers, canners, curly cutters, deep fryers, griddles, grills, d …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆